tirzepatide.vs semaglutide Tirzepatide Vs. For Weight Loss – Forbes Health Tirzepatide vs. Semaglutide: What the

Dealing with an illness like COVID-19 is a temporary hurdle

Ethics declarations Conflict of Interest Genki Sato has nothing to disclose

doi: 10.1007/s11695-019-03734-6 6 ApovianCM

Real-world evidence from observational studies consistently shows that GLP-1 RA use is associated with reduced risk of hepatic decompensation even in patients with established cirrhosis, supporting cautious use in this population

Therefore, while Wegovy itself does not directly cause kidney stones, the indirect effects of reduced fluid intake or fluid loss through gastrointestinal symptoms could theoretically increase risk in susceptible individuals